Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Dzeus Climax Control Wipes

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 7 g/100 mL
Other brand names
Dosage form
Cloth
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
January 17, 2024
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Benzocaine 7 g/100 mL
Other brand names
Dosage form
Cloth
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
January 17, 2024
Manufacturer
Sambria Pharmaceuticals, LLC
Registration number
M017
NDC root
54723-006
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This medication is designed to help you manage premature ejaculation, a condition that can affect your sexual experience. It works by temporarily prolonging the time it takes for ejaculation to occur, allowing for a more satisfying sexual encounter. If you're looking for support in this area, this drug may be a helpful option for you.

Uses

If you're looking for ways to enhance your sexual experience, this medication can help. It aids in the prevention of premature ejaculation, allowing you to feel more in control during intimate moments. Additionally, it can temporarily prolong the time until ejaculation, which may lead to a more satisfying experience for both you and your partner.

Dosage and Administration

To use this product effectively, start by applying a small amount to the head and shape of the penis using a wipe. It's important to do this before intercourse, or follow your doctor's specific instructions. Make sure to let the product dry completely before engaging in intercourse to ensure it works properly.

After intercourse, remember to wash off the product. This medication is not meant for oral use, so be sure to use it only as directed. Following these steps will help you use the product safely and effectively.

What to Avoid

You can feel confident using this medication, as there are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence mentioned in the provided information. This means that, based on the available details, there are no particular instructions advising against taking or using this medication. Always remember to consult with your healthcare provider if you have any questions or concerns about your treatment.

Side Effects

When using this product, it's important to be aware of potential side effects. You should only apply it to intact skin and avoid using it on broken or inflamed areas. If you are pregnant or breastfeeding, consult a healthcare professional before use. Be cautious to keep the product away from your eyes.

If you experience any rash or irritation, such as burning or itching, or if the product does not provide relief as expected, stop using it and consult your doctor. Persistent symptoms may indicate a condition that requires medical attention.

Warnings and Precautions

This product is for external use only, so please avoid applying it to broken or inflamed skin. If you are pregnant or breastfeeding, it's important to consult a healthcare professional before using this product. Be careful to keep it away from your eyes during application.

If you find that the product does not relieve your symptoms as expected, or if you or your partner experience any rash or irritation (like burning or itching), stop using it and contact your doctor. Additionally, if you suspect that premature ejaculation may be linked to a medical condition, seek medical advice. In case of accidental ingestion, seek emergency medical help and contact poison control right away.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While the specific signs of an overdose are not detailed, common symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's crucial to provide them with as much information as possible about the substance taken and the amount, if known. Remember, acting quickly can make a significant difference in your health and safety.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

It's important to keep this medication out of reach of children to prevent accidental ingestion. If a child does ingest it, you should seek professional help right away and contact poison control for guidance. Taking these precautions can help ensure your child's safety.

Geriatric Use

While there is no specific information about the use of DZEUS CLIMAX CONTROL WIPES in older adults, it’s important to approach any new product with caution. Since the drug insert does not mention dosage adjustments or safety concerns for elderly patients, you should consider consulting with a healthcare professional before using this product. This is especially important if you or your loved one have any underlying health conditions or are taking other medications. Always prioritize safety and well-being when trying new products.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to be adjusted based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary changes to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver condition. They can help monitor your liver function and make any necessary adjustments to your treatment plan.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that this medication is generally considered safe to use alongside other treatments and tests. However, every individual is different, and your healthcare provider can help ensure that your overall treatment plan is safe and effective for you. Always feel free to ask questions or express any concerns you may have regarding your medications or tests.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at a temperature between 20°-25 °C (68°-77 °F). This temperature range helps maintain the product's effectiveness and safety.

When handling the product, be sure to do so with clean hands and in a clean environment to avoid contamination. Always follow any specific disposal instructions provided to ensure safe and responsible disposal of any components.

Additional Information

You should apply a small amount of the product to the head and shape of the penis before intercourse, using a wipe for application. Make sure to wash it off after intercourse and allow the product to dry before engaging in sexual activity. Remember, this product is for topical use only and is not suitable for oral use. Always follow your doctor's instructions regarding its use.

FAQ

What is the purpose of this drug?

This drug aids in the prevention of premature ejaculation and temporarily prolongs the time until ejaculation.

How should I use this product?

Use a wipe to apply a small amount of the product to the head and shape of the penis before intercourse. Allow the product to dry and wash it off after intercourse.

Is this product safe for everyone?

This product is for external use only and should not be used on broken or inflamed skin. If you are pregnant or breastfeeding, consult a health professional before use.

What should I do if I experience irritation?

Stop using the product and ask a doctor if you or your partner develop a rash or irritation, such as burning or itching, or if symptoms persist.

What should I do in case of ingestion?

If ingested, seek professional assistance and contact poison control immediately.

Are there any specific storage instructions?

Store the product between 20°-25 °C (68°-77 °F).

Packaging Info

Below are the non-prescription pack sizes of Dzeus Climax Control Wipes (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Dzeus Climax Control Wipes.
Details

Drug Information (PDF)

This file contains official product information for Dzeus Climax Control Wipes, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the prevention of premature ejaculation in adult males. It aids in temporarily prolonging the time until ejaculation, thereby enhancing sexual performance and satisfaction.

Limitations of Use: This drug is intended for use in adult males only and is not indicated for use in females or pediatric populations.

Dosage and Administration

Healthcare professionals should instruct patients to apply a small amount of the product to the head and shaft of the penis using a wipe prior to intercourse, or as directed by a physician. It is essential to allow the product to dry completely before engaging in sexual activity. After intercourse, the product should be washed off thoroughly.

This product is not intended for oral use and should be utilized strictly as directed.

Contraindications

There are no contraindications listed for the use of this product. It is important to evaluate each patient's individual circumstances and medical history when considering treatment options.

Warnings and Precautions

The product is intended for external use only and should not be applied to broken or inflamed skin. Healthcare professionals should advise patients to consult with a health professional prior to use if they are pregnant or breastfeeding.

During application, it is crucial to avoid contact with the eyes. Patients should be instructed to discontinue use and seek medical advice if the product fails to provide relief when used as directed. Additionally, if premature ejaculation is suspected to be related to an underlying condition that requires medical supervision, consultation with a healthcare provider is recommended.

Patients should also be vigilant for any adverse reactions, such as rash or irritation, including burning or itching, in themselves or their partners. If any of these symptoms occur or if symptoms persist, it is essential to stop using the product and consult a healthcare professional.

In the event of ingestion, immediate professional assistance should be sought, and poison control should be contacted without delay.

Side Effects

Patients should be aware that this product is for external use only and should not be applied to broken or inflamed skin. It is advised that individuals who are pregnant or breastfeeding consult a healthcare professional prior to use. During application, care should be taken to avoid contact with the eyes.

In the event that the product does not provide relief when used as directed, or if premature ejaculation is suspected to be due to an underlying condition requiring medical supervision, patients should stop using the product and consult a doctor. Additionally, if either the patient or their partner experiences a rash or irritation, such as burning or itching, it is recommended to discontinue use and seek medical advice. Patients should also be vigilant for any persistent symptoms and consult a healthcare provider if such symptoms occur.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Dzeus Climax Control Wipes (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Dzeus Climax Control Wipes.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of ingestion, it is crucial to seek professional assistance and contact poison control immediately.

Geriatric Use

There is no specific information regarding the use of DZEUS CLIMAX CONTROL WIPES in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when considering the use of this product in elderly patients, as the absence of data necessitates careful monitoring and assessment of individual patient needs and responses.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and breastfeeding safety. Healthcare providers should consider individual circumstances and the specific health needs of the patient when making recommendations.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on the clinical scenario.

Furthermore, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous monitoring and reassessment of the patient's condition are vital to ensure optimal outcomes.

In summary, while specific overdosage information is not available, healthcare professionals should remain vigilant and prepared to implement standard overdose management strategies.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. No specific non-teratogenic effects have been identified. Additionally, there are no detailed findings related to nonclinical toxicology or animal pharmacology and toxicology available.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients that in the event of ingestion of the product, it is crucial to seek professional assistance immediately. Patients should be instructed to contact poison control without delay to ensure appropriate management and care. It is important for patients to understand the seriousness of this action and to act swiftly to mitigate any potential risks associated with ingestion.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the temperature range of 20° to 25 °C (68° to 77 °F) to maintain its efficacy and stability. Proper storage conditions should be ensured to prevent any degradation of the product.

Additional Clinical Information

The product is administered topically, with a specific application method involving the use of a wipe to apply a small amount to the head and shaft of the penis prior to intercourse. It is essential for patients to wash off the product after intercourse and allow it to dry before engaging in sexual activity. The product is not suitable for oral use and should be used as directed by a healthcare professional.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Dzeus Climax Control Wipes, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Dzeus Climax Control Wipes, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.